Enhancing translation: A need to leverage complex preclinical models of addictive drugs to accelerate substance use treatment options
Pharmacology Biochemistry and Behavior · 2024
DOI: 10.1016/j.pbb.2024.173836 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmacology Biochemistry and Behavior, 2024. Verfasst von Christa Corley und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY, USA. Hauptthemen laut MEDLINE: Substance-Related Disorders, Translational Research, Biomedical, Disease Models, Animal. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 518 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDA NIH HHS, National Institutes of Health, National Institute on Drug Abuse.
Abstract (Originalsprache)
Preclinical models of addictive drugs have been developed for decades to model aspects of the clinical experience in substance use disorders (SUDs). These include passive exposure as well as volitional intake models across addictive drugs and have been utilized to also measure withdrawal symptomatology and potential neurobehavioral mechanisms underlying relapse to drug seeking or taking. There are a number of Food and Drug Administration (FDA)-approved medications for SUDs, however, many demonstrate low clinical efficacy as well as potential sex differences, and we also note gaps in the continuum of care for certain aspects of clinical experiences in individuals who use drugs. In this review, we provide a comprehensive update on both frequently utilized and novel behavioral models of addiction with a focus on translational value to the clinical experience and highlight the need for preclinical research to follow epidemiological trends in drug use patterns to stay abreast of clinical treatment needs. We then note areas in which models could be improved to enhance the medications development pipeline through efforts to enhance translation of preclinical models. Next, we describe neuroscience efforts that can be leveraged to identify novel biological mechanisms to enhance medications development efforts for SUDs, focusing specifically on advances in brain transcriptomics approaches that can provide comprehensive screening and identification of novel targets. Together, the confluence of this review demonstrates the need for careful selection of behavioral models and methodological parameters that better approximate the clinical experience combined with cutting edge neuroscience techniques to advance the medications development pipeline for SUDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY, USA.
- RTI International, Research Triangle Park, NC, USA.
- Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
- Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY, USA. Electronic address: cdgips2@uky.edu.
Förderung
- NIDA NIH HHS
- National Institutes of Health
- National Institute on Drug Abuse
Zitieren
APA
Corley, C., Craig, A., Sadek, S., Marusich, J. A., Chehimi, S. N., White, A. M., Holdiness, L. J., Reiner, B. C., & Gipson, C. D. (2024). Enhancing translation: A need to leverage complex preclinical models of addictive drugs to accelerate substance use treatment options. Pharmacology Biochemistry and Behavior. https://doi.org/10.1016/j.pbb.2024.173836
Vancouver
Corley C, Craig A, Sadek S, Marusich JA, Chehimi SN, White AM, et al. Enhancing translation: A need to leverage complex preclinical models of addictive drugs to accelerate substance use treatment options. Pharmacology Biochemistry and Behavior. 2024. doi:10.1016/j.pbb.2024.173836
BibTeX
@article{Corley2024,
author = {Corley, Christa and Craig, Ashley and Sadek, Safiyah and Marusich, Julie A and Chehimi, Samar N and White, Ashley M and Holdiness, Lexi J and Reiner, Benjamin C and Gipson, Cassandra D},
title = {Enhancing translation: A need to leverage complex preclinical models of addictive drugs to accelerate substance use treatment options},
journal = {Pharmacology Biochemistry and Behavior},
year = {2024},
doi = {10.1016/j.pbb.2024.173836}
}
EUVIMED